Acumen Pharmaceuticals, Inc. (ABOS)
NASDAQ: ABOS · Real-Time Price · USD
2.250
+0.080 (3.69%)
At close: Jul 17, 2026, 4:00 PM EDT
2.220
-0.030 (-1.33%)
After-hours: Jul 17, 2026, 7:59 PM EDT
Acumen Pharmaceuticals Market Cap
Acumen Pharmaceuticals has a market cap or net worth of $162.51 million as of July 17, 2026. Its market cap has increased by 94.41% in one year.
Market Cap
162.51M
Enterprise Value
65.28M
1-Year Change
94.41%
Ranking
Category
Stock Price
$2.25
ChartMarket Cap Chart
Since the IPO on July 1, 2021, Acumen Pharmaceuticals's market cap has decreased from $618.43M to $162.51M, a decrease of -73.72%. That is a compound annual growth rate of -23.27%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 162.51M | 27.15% |
| Dec 31, 2025 | 127.81M | 23.68% |
| Dec 31, 2024 | 103.34M | -53.53% |
| Dec 29, 2023 | 222.38M | 0.62% |
| Dec 30, 2022 | 221.00M | -19.22% |
| Dec 31, 2021 | 273.58M | -55.76% |
| Jul 1, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Oramed Pharmaceuticals | 165.75M |
| OnKure Therapeutics | 165.62M |
| Caribou Biosciences | 164.64M |
| Alector | 163.21M |
| Corbus Pharmaceuticals Holdings | 163.04M |
| Equillium | 158.07M |
| PepGen | 155.63M |
| LENZ Therapeutics | 153.01M |